Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma.

Hepatocellular carcinoma (HCC) is one of the major malignancies worldwide. We have previously characterized global gene expression patterns in HCC using microarrays. Here, we report the analysis of genomic DNA copy number among 49 HCC samples using BAC array-based comparative genomic hybridization (CGH). We observed recurrent and characteristic chromosomal aberrations, including frequent DNA copy number gains of 1q, 6p, 8q and 20q, and losses of 4q, 8p, 13q, 16q and 17p. We correlated gene expression with array CGH data, and identified a set of genes whose expression levels correlated with common chromosomal aberrations in HCC. Especially, we noticed that high expression of Jab1 in HCC significantly correlated with DNA copy number gain at 8q. Quantitative microsatellite analysis further confirmed DNA copy number gain at the Jab1 locus. Overexpression of Jab1 in HCC was also validated using real-time RT-PCR, and Jab1 protein levels were studied by immunohistochemistry on tissue microarrays. Functional analysis in HCC cell lines demonstrated that Jab1 may regulate HCC cell proliferation, thereby having a potential role in HCC development. In conclusion, this study shows that array-based CGH provides high resolution mapping of chromosomal aberrations in HCC, and demonstrates the feasibility of correlating array CGH data with gene expression data to identify novel oncogenes and tumor suppressor genes.

[1]  N. Wong,et al.  Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis. , 1999, The American journal of pathology.

[2]  J. Kato,et al.  Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1 , 1999, Nature.

[3]  Wen-Lin Kuo,et al.  Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. , 2003, Cancer research.

[4]  Xuebo Liu,et al.  p38 JAB1 Binds to the Intracellular Precursor of the Lutropin/Choriogonadotropin Receptor and Promotes Its Degradation* , 2000, The Journal of Biological Chemistry.

[5]  W. Kuo,et al.  Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene , 2000, Nature Genetics.

[6]  R. Pardi,et al.  Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity , 2000, Nature.

[7]  K. Nakashiro,et al.  Skp2 and Jab1 Expression Are Associated with Inverse Expression of p27KIP1 and Poor Prognosis in Oral Squamous Cell Carcinomas , 2003, Oncology.

[8]  Xuesong Cao,et al.  Jab1 antagonizes TGF‐β signaling by inducing Smad4 degradation , 2002 .

[9]  Y. Dong,et al.  Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[10]  N. Nishida,et al.  Chromosomal instability and human hepatocarcinogenesis. , 2003, Histology and histopathology.

[11]  T. Godfrey,et al.  Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. , 2000, Cancer research.

[12]  M. Oka,et al.  Analysis of DNA copy number aberrations in hepatitis C virus-associated hepatocellular carcinomas by conventional CGH and array CGH , 2004, Modern Pathology.

[13]  Ajay N. Jain,et al.  Fully automatic quantification of microarray image data. , 2002, Genome research.

[14]  D. Botstein,et al.  Gene expression patterns in human liver cancers. , 2002, Molecular biology of the cell.

[15]  H B el-Serag.  Epidemiology of hepatocellular carcinoma. , 2001, Clinics in liver disease.

[16]  M. Feitelson,et al.  Genetic mechanisms of hepatocarcinogenesis , 2002, Oncogene.

[17]  J. Kato,et al.  Prognostic significance of localized p27Kip1 and potential role of Jab1/CSN5 in pancreatic cancer. , 2004, Oncology reports.

[18]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  P. Jallepalli,et al.  Chromosome segregation and cancer: cutting through the mystery , 2001, Nature Reviews Cancer.

[20]  N. Nishida,et al.  Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. , 1994, Cancer research.

[21]  O. Kallioniemi,et al.  Tissue microarray technology for high-throughput molecular profiling of cancer. , 2001, Human molecular genetics.

[22]  S. Thorgeirsson,et al.  Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization , 1999, Hepatology.

[23]  C. J. Chen,et al.  Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. , 1993, Biochemical and biophysical research communications.

[24]  Hofmann,et al.  Unified nomenclature for the COP9 signalosome and its subunits: an essential regulator of development , 2000, Trends in genetics : TIG.

[25]  M. Lishner,et al.  Analysis of chromosomal aberrations in large hepatocellular carcinomas by comparative genomic hybridization. , 2001, Cancer genetics and cytogenetics.

[26]  C. Kittas,et al.  Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1). , 2003, Cancer research.

[27]  D. Parkin,et al.  Global cancer statistics in the year 2000. , 2001, The Lancet. Oncology.

[28]  K. Aldape,et al.  Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay. , 2001, The American journal of pathology.

[29]  Ash A. Alizadeh,et al.  Genome-wide analysis of DNA copy-number changes using cDNA microarrays , 1999, Nature Genetics.

[30]  D. Pinkel,et al.  Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors , 2022 .

[31]  Jacques Ferlay,et al.  Estimating the world cancer burden: Globocan 2000 , 2001, International journal of cancer.

[32]  M. Takagi,et al.  Expression of Cyclin‐dependent Kinase Inhibitor p27/Kipl and AP‐1 Coactivator p38/Jabl Correlates with Differentiation of Embryonal Rhabdomyosarcoma , 2002, Japanese journal of cancer research : Gann.

[33]  K. Okita,et al.  Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: Their relationship to clinicopathological features , 1999, Hepatology.

[34]  Ajay N. Jain,et al.  Array-based comparative genomic hybridization for the differential diagnosis of renal cell cancer. , 2002, Cancer research.

[35]  Minoru Yoshida,et al.  The Cytoplasmic Shuttling and Subsequent Degradation of p27Kip1 Mediated by Jab1/CSN5 and the COP9 Signalosome Complex* , 2002, The Journal of Biological Chemistry.

[36]  H. El‐Serag.  Hepatocellular carcinoma: an epidemiologic view. , 2002, Journal of clinical gastroenterology.

[37]  S. Park,et al.  Jab1/CSN5, a Component of the COP9 Signalosome, Regulates Transforming Growth Factor β Signaling by Binding to Smad7 and Promoting Its Degradation , 2004, Molecular and Cellular Biology.

[38]  W. Kuo,et al.  High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays , 1998, Nature Genetics.

[39]  J W Gray,et al.  An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer. , 2000, Cancer research.

[40]  M. Buendia.  Genetics of hepatocellular carcinoma. , 2000, Seminars in cancer biology.

[41]  D. Chamovitz,et al.  JAB1/CSN5 and the COP9 signalosome , 2001, EMBO reports.

[42]  Rui Li,et al.  An integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinoma , 2005, Oncogene.

[43]  S. Bustin.  Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. , 2000, Journal of molecular endocrinology.

[44]  T. Toda,et al.  A new group of conserved coactivators that increase the specificity of AP-1 transcription factors , 1996, Nature.

[45]  C. Scheidereit,et al.  The Bcl-3 oncoprotein acts as a bridging factor between NF-κB/Rel and nuclear co-regulators , 1999, Oncogene.

[46]  Yan Fang,et al.  Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization , 2000 .

[47]  Ash A. Alizadeh,et al.  Genome-wide analysis of DNA copy number variation in breast cancer using DNA microarrays , 1999, Nature Genetics.

[48]  J M Trent,et al.  Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization , 2000, Genes, chromosomes & cancer.

[49]  Ivar Siccama,et al.  Genomic profiling of gastric cancer predicts lymph node status and survival , 2003, Oncogene.

[50]  L. Murphy,et al.  Psoriasin interacts with Jab1 and influences breast cancer progression. , 2003, Cancer research.

[51]  J. Trent,et al.  Recurrent chromosome changes in 62 primary gastric carcinomas detected by comparative genomic hybridization. , 2000, Cancer genetics and cytogenetics.

[52]  E. Milgrom,et al.  JAB1 Interacts with Both the Progesterone Receptor and SRC-1* , 2000, The Journal of Biological Chemistry.